Pharmaceutical company Pfizer said today it is launching a Web site aimed at educating healthcare professionals, patients and the public about medicine safety."We want to increase understanding of the industry’s system for ensuring medicine safety," said Dr. Joseph M. Feczko, chief medical officer for Pfizer.
Pfizer Aims To Strengthen Pharm. Business With Vicuron
It was announced today that Pfizer will be acquiring Vicuron Pharmaceuticals, a company that focuses on novel anti-infectives for both hospital-based and community-acquired infections.
Pfizer Favors Anti-Infectives
The big pharmaceutical concern picks up anti-infective maker Vicuron for $1.9 billion USD.
Pfizer Buying Vicuron For Nearly $2 Billion
Pfizer is acquiring Vicuron Pharmaceuticals, a company that is dedicated to novel anti-infectives for both hospital-based and community-acquired infections.
Pfizer and FDA Discuss Possible Changes To Viagra Label
Pfizer Inc., the maker of Viagra is participating in discussions with the U.S. Food and Drug Administration (FDA) concerning a possible revision of the drug’s label.
Pfizer Revenues Up From Last Year
Pfizer revenues for the first quarter of 2005 grew 5 percent to $13.091 billion, compared to the first quarter of 2004, reflecting strong performances by Lipitor, Zithromax, and other product lines.
Pfizer’s Celebrex Gets New FDA Labeling
Pfizer said it will work with the U.S. Food and Drug Administration (FDA) to add expanded risk information in the Celebrex label following an FDA decision…
Pfizer Gets FDA Approval on Depo-subQ provera 104
Pfizer has received U.S. Food and Drug Administration approval for depo-subQ provera 104 for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.
Microsoft, Pfizer Go Hard After Viagra Spammers
Microsoft and Viagra maker Phizer have teamed up to sue Viagra spammers. Here’s how the blogs have reacted …
Microsoft, Pfizer Target Viagra Spam
A joint effort being conducted by Microsoft and Pfizer are attempting to put a stop, or at least a dent, in the enormous amounts of Viagra-based spam mailings.